Developer docs
API playgroundTry for free, no card

Search company profiles

InMode

Full company profile

uuid00034ic

Namestring
InMode
Legal namestring
InMode Ltd.
Websiteurl
inmodemd.com
Company typeenum
Public
Founded yearint
2008
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersLake Forest, United States
HQ citystring
Lake Forest
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
aesthetic medical devices, radiofrequency technology, minimally invasive procedures, medical aesthetic platforms, laser aesthetic systems
Industry2 codes
1Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryYes
2Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
CodeHLAHADAMPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Aesthetic Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Capital Equipment (Systems/Workstations)
TypeHardware Sales
Description

Sale of multi-technology aesthetic platforms (EvolveX, EmpowerRF, OptimasMAX, IgniteRF, Define, Luxora, Triton, Morpheus8) to aesthetic practices, dermatology clinics, and hospitals. These are high-ticket capital equipment purchases requiring direct sales engagement.

stocktitan.net
2Consumables and Handpieces
TypeSubscription Recurring
Description

Recurring revenue from disposable components including treatment tips, electrodes, and applicators. Consumables/servicing revenue grew 2.7% in 2025, indicating steady recurring revenue stream from installed base.

seekingalpha.com
3Service and Maintenance
TypeSubscription Recurring
Description

Service contracts and maintenance revenue from installed base of equipment. Q1 2026 consumables and service revenues of $81.4 million, up 3% year-over-year.

aijourn.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Infrastructure
Pricing details1 tier
1Enterprise capital equipment with modular technology platforms
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Multi-technology workstations (EvolveX, EmpowerRF, OptimasMAX, etc.) represent significant capital investments for aesthetic practices. Pricing varies by platform configuration and selected technology modules. No public pricing available - requires consultation with sales team.

inmodemd.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 16 records shown
1Morpheus8
Description

Fractional radiofrequency microneedling technology platform for skin rejuvenation and body contouring

inmodemd.com
+15 more records
Core offering1 text field

InMode develops, manufactures, and markets radiofrequency (RF), laser, and IPL-based medical aesthetic platforms for minimally invasive and non-invasive procedures. The company sells multi-technology workstations such as Morpheus8 Burst, IgniteRF, EvolveX, EmpowerRF, OptimasMAX, Triton, Solaria, Define, Luxora, and ApexRF to aesthetic practices, dermatology clinics, plastic surgery centers, OB-GYN practices, and hospitals, supplemented by recurring revenue from consumables and service contracts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 2.7% growth in consumables/servicing revenue in 2025
+4 more records
Product overview1 text field

InMode develops, manufactures, and markets platforms that harness novel radio-frequency (RF) based technology for minimally-invasive and non-invasive medical aesthetic procedures. The company operates a multi-platform architecture where foundational RF technologies (Morpheus8, QuantumRF, RFAL) are delivered through multiple workstation configurations. Core platforms include: ApexRF (circulatory wellness), Define (facial treatments), EmpowerRF (women's wellness), EvolveX (hands-free body transformation), IgniteRF (minimally invasive RFAL), Luxora (soft tissue contraction), OptimasMAX (multi-functional), Solaria (CO2 laser resurfacing), Triton (hair removal), and EmbraceRF (facial refinement). These platforms incorporate specific treatment technologies including Morpheus8 Burst/Burst Deep (fractional RF microneedling), Lumecca Peak (IPL), VasculazeMAX (vascular), Fusion Light/Dark (hair removal), Tone/Tite/Transform (body treatments), VTone/FormaV (women's wellness), AccuTite/FaceTite/BodyTite (RFAL), Forma/Plus (skin tightening), Define Cheek/Chin (facial RF), Picofy (picosecond laser), and QuantumRF (minimally invasive soft tissue contraction). Treatments span face, body, skin, hair removal, women's wellness, and circulatory wellness applications across plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology specialties.

Product and service13 records
1Morpheus8 Burst
CategoryMedical Aesthetic Workstation - RF Microneedling
Description

Fractional radiofrequency (RF) microneedling workstation equipped with proprietary Burst and Scale functionalities that automatically deploy bipolar RF to multi-level soft tissue depths, contracting adipose and dermal tissue in a single pulse. Features interchangeable tips including Prime 12 pin, 24 pin, and Resurfacing 24 pin for customized treatments. For aesthetic practices, dermatology clinics, and plastic surgery centers.

2ApexRF
CategoryMedical Aesthetic Workstation - Circulatory Wellness
Description

Non-invasive circulatory wellness workstation using bipolar radiofrequency (RF) to safely improve blood circulation without side effects or surgery. Includes Apex Circulatory, Tone, Morpheus8, and Morpheus8 Deep components for personalized treatments. For aesthetic practices and wellness clinics.

3IgniteRF
CategoryMedical Aesthetic Workstation - RFAL Lipolysis
Description

Minimally invasive RFAL (Radiofrequency-Assisted Lipolysis) platform that delivers surgical-like results without large scars or prolonged downtime. Includes BodyTite Turbo, FaceTite Turbo, QuantumRF, BodyTite IgniteRF, FaceTite IgniteRF, AccuTite IgniteRF, Morpheus8 Burst, and Morpheus8 Burst Deep. For plastic surgery centers and cosmetic surgery practices.

4QuantumRF
CategoryMedical Aesthetic Technology - Minimally Invasive RF
Description

Minimally invasive soft tissue contraction technology that deploys fractionated radiofrequency (FRF) to maximal depths through lightweight polymer-coated cannulas without damaging the dermis. Available in three cannula sizes (QuantumRF 25, 17, 10) for customizable treatments. For plastic surgeons and cosmetic practices.

5EvolveX
CategoryMedical Aesthetic Workstation - Hands-Free Body Treatment
Description

Hands-free body transformation platform combining three technologies: Tite (Bipolar RF for skin treatment), Tone (EMS for muscle toning), and Transform (Bipolar RF and EMS combined for body and muscle transformation). Procedures can be combined for synergistic layering treatments. For medical spas and aesthetic practices.

6Define
CategoryMedical Aesthetic Workstation - Facial Treatment
Description

Customizable combination facial workstation with hybrid configuration combining technician-operated and hands-free technologies including Morpheus8, Define Cheek, Define Chin, and Forma for targeted facial procedures in all facial regions. For dermatologists, plastic surgeons, and aesthetic practices.

7EmpowerRF
CategoryMedical Aesthetic Workstation - Women's Wellness
Description

Women's wellness platform delivering intravaginal EMS (VTone), bipolar RF deep heating (FormaV), fractional microneedling (Morpheus8/Morpheus8V), and electrical muscle stimulation (Tone) for pelvic floor rehabilitation, urinary incontinence treatment, and feminine wellness applications. For OB-GYNs and women's health practitioners.

8OptimasMAX
CategoryMedical Aesthetic Workstation - Multi-Functional
Description

Multi-functional aesthetic platform combining fractional radiofrequency (FRF), intense pulsed light (IPL), hair removal, and vascular treatments. Includes Morpheus8 Burst, Lumecca Peak, Fusion Light/Dark, VasculazeMAX, and Forma/Plus for comprehensive in-demand procedures. For dermatology clinics and aesthetic practices.

9Solaria
CategoryMedical Aesthetic Workstation - CO2 Laser Resurfacing
Description

CO2 fractional laser resurfacing platform with advanced carbon dioxide fractional laser technology serving as the gold standard for non-surgical skin resurfacing, effectively addressing a wide range of skin concerns. For dermatologists and aesthetic practices.

10Triton
CategoryMedical Aesthetic Workstation - Hair Removal
Description

Multi-wavelength hair removal platform using patented Fusion Technology combining three wavelengths for permanent hair removal on all skin types up to VI. Includes Triton Duo Light (optimized for lighter skin) and Triton Duo Dark (for darker skin tones). For medical spas and dermatology clinics.

11Luxora
CategoryMedical Aesthetic Workstation - Soft Tissue Contraction
Description

Comprehensive soft tissue contraction workstation combining QuantumRF, Morpheus8 Burst, and Morpheus8 Burst Deep technologies in an all-in-one solution. Ideal for patients seeking remarkable results without being candidates for more excisional procedures. For plastic surgeons and cosmetic practices.

12EmbraceRF
CategoryMedical Aesthetic Workstation - Facial Contouring
Description

Minimally invasive facial contouring platform combining AccuTite, FaceTite, and Morpheus8 technologies for comprehensive facial rejuvenation procedures. For plastic surgeons and cosmetic surgery centers.

13Picofy
CategoryMedical Aesthetic Workstation - Picosecond Laser
Description

Super-fast picosecond laser workstation for non-invasive treatment of acne scars, wrinkles, benign pigmented lesions, and unwanted tattoos with rapid pulse delivery. For dermatologists, medical spas, and tattoo removal specialists.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Miami-based aesthetic practice recognized as a 2025 Top Morpheus8 Provider by InMode, distinguishing the clinic for consistent treatment delivery, clinical proficiency, and sustained patient demand. Featured in InMode's Find a Provider directory.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor in laser and RF aesthetic devices for hair removal, body contouring, and skin rejuvenation. Overlaps with InMode's Triton, Lumecca Peak, and EvolveX platforms. Acquired by Hologic in 2024 to scale the aesthetic business.

TypeDirect peer
Description

Direct competitor offering laser and energy-based aesthetic devices including AviClear, excel V, and truSculpt. Targets the same dermatology and plastic surgery customers as InMode with similar capital equipment plus consumables model.

TypeDirect peer
Description

Direct competitor with Thermage RF skin tightening and Fraxel fractional laser — the historical category leaders in the same RF and laser modalities as InMode's Thermage-equivalent platforms and Morpheus8/Solaria.

TypeDirect peer
Description

Global competitor in RF, laser, and IPL aesthetic systems (Accent, Soprano, Harmony). Competes head-to-head with InMode in plastic surgery, dermatology, and medspa channels across international markets.

TypeDirect peer
Description

Competitor in RF and IPL aesthetic devices (Venus Versa, Venus Legacy) targeting the same medspa and dermatology customers. Smaller scale but overlapping product portfolio and business model.

TypeDirect peer
Description

Private competitor in aesthetic lasers (BBL, Halo, Profractional, diVa). Competes with InMode's Solaria, Lumecca Peak, and EmpowerRF platforms in plastic surgery and dermatology practices.

TypeDirect peer
Description

Founded by InMode's co-founders prior to InMode. Direct competitor in RF (eMatrix, VelaShape), laser, and IPL aesthetic devices with strong brand recognition among plastic surgeons and dermatologists.

TypeBroad incumbent
Description

Broader incumbent in medical aesthetics via Botox, CoolSculpting, and skin care. Competes with InMode for the same patient wallet share, particularly in plastic surgery and dermatology channels, though focused on injectables and cryolipolysis rather than RF.

TypeBroad incumbent
Description

Broader incumbent in aesthetics with Sculptra, Restylane, and emerging portfolio. Adjacent in the same end markets (plastic surgery, dermatology, medspas) and increasingly overlapping as the aesthetic market converges around combination therapies.

TypeBroad incumbent
Description

Acquired by Boston Scientific in 2024; historical leader in aesthetic lasers (M22, LightSheer) and strong in the same plastic surgery and dermatology channels as InMode's Triton and Solaria platforms.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InMode

Medical Aesthetic Devicesinmodemd.com

InMode firmographics

Firmographics
Name
InMode
Legal name
InMode Ltd.
Website
https://inmodemd.com
Company type
Public
Founded year
2008
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

InMode industry classification

Industry
Product category
Medical Aesthetic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
akta.pro secondary industry
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

  • Aesthetic medical devices
  • Radiofrequency technology
  • Minimally invasive procedures
  • Medical aesthetic platforms
  • Laser aesthetic systems

Where InMode is headquartered

Location

Headquarters

HQ city
Lake Forest
HQ country
United States
HQ region
North America

Offices2 records

Markets served

InMode business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Infrastructure

Revenue model

  1. Capital Equipment (Systems/Workstations): Sale of multi-technology aesthetic platforms (EvolveX, EmpowerRF, OptimasMAX, IgniteRF, Define, Luxora, Triton, Morpheus8) to aesthetic practices, dermatology clinics, and hospitals. These are high-ticket capital equipment purchases requiring direct sales engagement.
  2. Consumables and Handpieces: Recurring revenue from disposable components including treatment tips, electrodes, and applicators. Consumables/servicing revenue grew 2.7% in 2025, indicating steady recurring revenue stream from installed base.
  3. Service and Maintenance: Service contracts and maintenance revenue from installed base of equipment. Q1 2026 consumables and service revenues of $81.4 million, up 3% year-over-year.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goEnterprise capital equipment with modular technology platforms

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

InMode product offering

Product offering

Core offering

InMode develops, manufactures, and markets radiofrequency (RF), laser, and IPL-based medical aesthetic platforms for minimally invasive and non-invasive procedures. The company sells multi-technology workstations such as Morpheus8 Burst, IgniteRF, EvolveX, EmpowerRF, OptimasMAX, Triton, Solaria, Define, Luxora, and ApexRF to aesthetic practices, dermatology clinics, plastic surgery centers, OB-GYN practices, and hospitals, supplemented by recurring revenue from consumables and service contracts.

Product overview

InMode develops, manufactures, and markets platforms that harness novel radio-frequency (RF) based technology for minimally-invasive and non-invasive medical aesthetic procedures. The company operates a multi-platform architecture where foundational RF technologies (Morpheus8, QuantumRF, RFAL) are delivered through multiple workstation configurations. Core platforms include: ApexRF (circulatory wellness), Define (facial treatments), EmpowerRF (women's wellness), EvolveX (hands-free body transformation), IgniteRF (minimally invasive RFAL), Luxora (soft tissue contraction), OptimasMAX (multi-functional), Solaria (CO2 laser resurfacing), Triton (hair removal), and EmbraceRF (facial refinement). These platforms incorporate specific treatment technologies including Morpheus8 Burst/Burst Deep (fractional RF microneedling), Lumecca Peak (IPL), VasculazeMAX (vascular), Fusion Light/Dark (hair removal), Tone/Tite/Transform (body treatments), VTone/FormaV (women's wellness), AccuTite/FaceTite/BodyTite (RFAL), Forma/Plus (skin tightening), Define Cheek/Chin (facial RF), Picofy (picosecond laser), and QuantumRF (minimally invasive soft tissue contraction). Treatments span face, body, skin, hair removal, women's wellness, and circulatory wellness applications across plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology specialties.

Differentiator

Problem solved

Functional benefit

Brands

  • Morpheus8: Fractional radiofrequency microneedling technology platform for skin rejuvenation and body contouring
  • EvolveX
  • EmpowerRF
  • QuantumRF
  • FaceTite
  • BodyTite
  • Forma
  • Lumecca Peak
  • AccuTite
  • Picofy
  • Solaria
  • Triton
  • Define
  • OptimasMAX
  • ApexRF
  • IgniteRF

Products and services

  • Morpheus8 Burst Fractional radiofrequency (RF) microneedling workstation equipped with proprietary Burst and Scale functionalities that automatically deploy bipolar RF to multi-level soft tissue depths, contracting adipose and dermal tissue in a single pulse. Features interchangeable tips including Prime 12 pin, 24 pin, and Resurfacing 24 pin for customized treatments. For aesthetic practices, dermatology clinics, and plastic surgery centers.
  • ApexRF Non-invasive circulatory wellness workstation using bipolar radiofrequency (RF) to safely improve blood circulation without side effects or surgery. Includes Apex Circulatory, Tone, Morpheus8, and Morpheus8 Deep components for personalized treatments. For aesthetic practices and wellness clinics.
  • IgniteRF Minimally invasive RFAL (Radiofrequency-Assisted Lipolysis) platform that delivers surgical-like results without large scars or prolonged downtime. Includes BodyTite Turbo, FaceTite Turbo, QuantumRF, BodyTite IgniteRF, FaceTite IgniteRF, AccuTite IgniteRF, Morpheus8 Burst, and Morpheus8 Burst Deep. For plastic surgery centers and cosmetic surgery practices.
  • QuantumRF Minimally invasive soft tissue contraction technology that deploys fractionated radiofrequency (FRF) to maximal depths through lightweight polymer-coated cannulas without damaging the dermis. Available in three cannula sizes (QuantumRF 25, 17, 10) for customizable treatments. For plastic surgeons and cosmetic practices.
  • EvolveX Hands-free body transformation platform combining three technologies: Tite (Bipolar RF for skin treatment), Tone (EMS for muscle toning), and Transform (Bipolar RF and EMS combined for body and muscle transformation). Procedures can be combined for synergistic layering treatments. For medical spas and aesthetic practices.
  • Define Customizable combination facial workstation with hybrid configuration combining technician-operated and hands-free technologies including Morpheus8, Define Cheek, Define Chin, and Forma for targeted facial procedures in all facial regions. For dermatologists, plastic surgeons, and aesthetic practices.
  • EmpowerRF Women's wellness platform delivering intravaginal EMS (VTone), bipolar RF deep heating (FormaV), fractional microneedling (Morpheus8/Morpheus8V), and electrical muscle stimulation (Tone) for pelvic floor rehabilitation, urinary incontinence treatment, and feminine wellness applications. For OB-GYNs and women's health practitioners.
  • OptimasMAX Multi-functional aesthetic platform combining fractional radiofrequency (FRF), intense pulsed light (IPL), hair removal, and vascular treatments. Includes Morpheus8 Burst, Lumecca Peak, Fusion Light/Dark, VasculazeMAX, and Forma/Plus for comprehensive in-demand procedures. For dermatology clinics and aesthetic practices.
  • Solaria CO2 fractional laser resurfacing platform with advanced carbon dioxide fractional laser technology serving as the gold standard for non-surgical skin resurfacing, effectively addressing a wide range of skin concerns. For dermatologists and aesthetic practices.
  • Triton Multi-wavelength hair removal platform using patented Fusion Technology combining three wavelengths for permanent hair removal on all skin types up to VI. Includes Triton Duo Light (optimized for lighter skin) and Triton Duo Dark (for darker skin tones). For medical spas and dermatology clinics.
  • Luxora Comprehensive soft tissue contraction workstation combining QuantumRF, Morpheus8 Burst, and Morpheus8 Burst Deep technologies in an all-in-one solution. Ideal for patients seeking remarkable results without being candidates for more excisional procedures. For plastic surgeons and cosmetic practices.
  • EmbraceRF Minimally invasive facial contouring platform combining AccuTite, FaceTite, and Morpheus8 technologies for comprehensive facial rejuvenation procedures. For plastic surgeons and cosmetic surgery centers.
  • Picofy Super-fast picosecond laser workstation for non-invasive treatment of acne scars, wrinkles, benign pigmented lesions, and unwanted tattoos with rapid pulse delivery. For dermatologists, medical spas, and tattoo removal specialists.

Quantifiable outcome

  • 2.7% growth in consumables/servicing revenue in 2025
  • +4 more outcomes

Companies that use InMode

Customer profile

Named customers13 records

Segments6 records

Ideal customer profiles2 records

InMode technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

InMode partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Med Aesthetics MiamiminorChannel Partner/ Reseller/ DistributorMiami-based aesthetic practice recognized as a 2025 Top Morpheus8 Provider by InMode, distinguishing the clinic for consistent treatment delivery, clinical proficiency, and sustained patient demand. Featured in InMode's Find a Provider directory.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

InMode competitors and assessment

Company assessment

Direct peers

  • Cynosure (Hologic): Direct competitor in laser and RF aesthetic devices for hair removal, body contouring, and skin rejuvenation. Overlaps with InMode's Triton, Lumecca Peak, and EvolveX platforms. Acquired by Hologic in 2024 to scale the aesthetic business.
  • Cutera: Direct competitor offering laser and energy-based aesthetic devices including AviClear, excel V, and truSculpt. Targets the same dermatology and plastic surgery customers as InMode with similar capital equipment plus consumables model.
  • Solta Medical (Bausch Health): Direct competitor with Thermage RF skin tightening and Fraxel fractional laser — the historical category leaders in the same RF and laser modalities as InMode's Thermage-equivalent platforms and Morpheus8/Solaria.
  • Alma Lasers: Global competitor in RF, laser, and IPL aesthetic systems (Accent, Soprano, Harmony). Competes head-to-head with InMode in plastic surgery, dermatology, and medspa channels across international markets.
  • Venus Concept: Competitor in RF and IPL aesthetic devices (Venus Versa, Venus Legacy) targeting the same medspa and dermatology customers. Smaller scale but overlapping product portfolio and business model.
  • Sciton: Private competitor in aesthetic lasers (BBL, Halo, Profractional, diVa). Competes with InMode's Solaria, Lumecca Peak, and EmpowerRF platforms in plastic surgery and dermatology practices.
  • Syneron-Candela: Founded by InMode's co-founders prior to InMode. Direct competitor in RF (eMatrix, VelaShape), laser, and IPL aesthetic devices with strong brand recognition among plastic surgeons and dermatologists.

Broad incumbents

  • AbbVie (Allergan Aesthetics): Broader incumbent in medical aesthetics via Botox, CoolSculpting, and skin care. Competes with InMode for the same patient wallet share, particularly in plastic surgery and dermatology channels, though focused on injectables and cryolipolysis rather than RF.
  • Galderma: Broader incumbent in aesthetics with Sculptra, Restylane, and emerging portfolio. Adjacent in the same end markets (plastic surgery, dermatology, medspas) and increasingly overlapping as the aesthetic market converges around combination therapies.
  • Lumenis (Boston Scientific): Acquired by Boston Scientific in 2024; historical leader in aesthetic lasers (M22, LightSheer) and strong in the same plastic surgery and dermatology channels as InMode's Triton and Solaria platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

InMode social profiles

Digital presence

InMode financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InMode leadership team

Management profile

Number of profiles

Profiles14 records

InMode subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

InMode funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InMode M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InMode

What does InMode do?

InMode develops, manufactures, and markets radiofrequency (RF), laser, and IPL-based medical aesthetic platforms for minimally invasive and non-invasive procedures. The company sells multi-technology workstations such as Morpheus8 Burst, IgniteRF, EvolveX, EmpowerRF, OptimasMAX, Triton, Solaria, Define, Luxora, and ApexRF to aesthetic practices, dermatology clinics, plastic surgery centers, OB-GYN practices, and hospitals, supplemented by recurring revenue from consumables and service contracts.

Is InMode a public or private company?

InMode is a public company. It is classified as public and is currently operating.

When was InMode founded?

InMode was founded in 2008. It employs 501 to 1,000 people.

Where is InMode based?

InMode is headquartered in Lake Forest, United States, in the North America region.

How does InMode make money?

Three revenue lines are on record. Capital Equipment (Systems/Workstations) is the primary driver. The others are consumables and Handpieces and service and Maintenance.

Who are InMode's main competitors?

Direct peers on record are Cynosure (Hologic), Cutera, Solta Medical (Bausch Health), Alma Lasers, Venus Concept, Sciton and Syneron-Candela. Broad incumbents are AbbVie (Allergan Aesthetics), Galderma and Lumenis (Boston Scientific).

Does InMode have an API?

No public API is recorded for InMode.

What industry is InMode in?

InMode's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ticker ReportFinancial Survey: LogicMark (OTCMKTS:LGMKD) and InMode (NASDAQ:INMD)InMode and LogicMark are compared on financial metrics, with InMode showing higher revenue ($370.49M vs $9.90M) and earnings ($93.83M vs -$9M). InMode has stronger institutional ownership (68% vs 7.9%) and a consensus target price of $16, implying 12.20% upside. InMode beats LogicMark on all 13 factors.Seeking AlphaInMode Stock: Hope Is Not Effective Investment Strategy, Neither Is Despair (NASDAQ:INMD)InMode's stock remains rangebound as US platform sales decline, but international growth and recurring consumables revenue provide stabilization. The company maintains a buy rating, downgraded from strong buy, citing cyclical softness and macro headwinds. Robust net cash of ~$497M and aggressive buybacks underpin a strong moat, though sentiment is hampered by leadership doubts and execution risk.Seeking AlphaInMode: Reasonably Valued But With Too Much Drama (NASDAQ:INMD)InMode Ltd. trades at a low 11.4x forward earnings but faces flat revenue and earnings growth. Q2 results showed non-GAAP operating margin dropping from 28% to 17%, with flat year-over-year revenues. Geopolitical risks, lack of management transparency, and discretionary product exposure further cloud its investment appeal.Defense WorldFinancial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)IDEXX Laboratories beats InMode on 12 of 14 factors, including higher revenue, earnings, and institutional ownership. IDEXX's consensus target price of $747 implies a 47.47% upside, versus InMode's 8.33% upside. IDEXX's stronger analyst rating and higher upside make it the more favorable investment.AInvestThe GLP-1 Aesthetics Wave: Why the Public Market Offers No Clean PlayAMP added ATTIVA, a subdermal RF device, to its portfolio, citing the GLP-1 era. The article argues no public stock offers a clean play, citing Cutera's bankruptcy and InMode's limited upside. It notes 63% of GLP-1 patients are new to aesthetics, but 60% report reduced spending.American Banking and Market NewsInMode Ltd. (NASDAQ:INMD) Given Consensus Rating of “Hold” by AnalystsAnalysts rate InMode Ltd. 'Hold' with an average price target of $16.00, while Weiss Ratings issued a 'sell' rating. The company reported Q2 EPS of $0.35, meeting estimates, with revenue of $95.59 million, up 0% year-over-year. Institutional ownership stands at 68.04%.PR NewswireInMode Advances RF Microneedling Comfort with the Launch of Morpheus8 CoolInMode launched Morpheus8 Cool, an RF microneedling handpiece with a cooling tip and interactive interface, available on the Morpheus8MAX platform. The device offers Guided Mode with preset parameters and Manual Mode for customization, aiming to improve comfort and safety. The launch follows positive feedback from providers at the Insider Summit.FinancialContent Business PageDr. Anita Narang Recognized Among Victoria's Top Optometrists While Advancing the Future of Eye CareDr. Anita Narang of Island Eyecare in Victoria, Canada, was named one of the city's Top 3 Optometrists by ThreeBestRated® for the sixth consecutive year, according to a press release dated August 29, 2026. The clinic has also received a 10,000 patients treated trophy from InMode for dry eye treatment and is expanding into age-related macular degeneration and blink mechanics.Markets DailyInMode Ltd. (NASDAQ:INMD) Receives $16.00 Consensus Target Price from AnalystsInMode Ltd. has received a consensus "Hold" recommendation from eight analysts with an average 1-year price target of $16.00, following recent reports from Weiss Ratings, Barclays, and Robert W. Baird. The company recently reported quarterly earnings that met consensus estimates, with revenue reaching $95.59 million against expectations of $94.89 million. Institutional investors have adjusted their holdings in the medical technology firm during the fourth quarter.Third NewsInMode Reports Steady Financial Performance in Q2 2026 with $95.6 Million RevenueInMode Ltd. reported Q2 2026 revenues of $95.6 million, matching the same period in 2025, while net income declined to $17.1 million from $26.7 million year-over-year due to higher costs of goods sold, product mix shifts, and increased marketing spending. The company completed a $87.8 million share buyback repurchasing 6.38 million shares and maintained a strong cash position of $501.1 million, with management projecting full-year 2026 revenues between $365 million and $375 million.